Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial

Hepatitis B ◽

Controlled Trial ◽

Hepatitis B Vaccination ◽

Open Label ◽

Effects of Sodium Glucose Co-Transporter 2 Inhibitor Canagliflozin in Patients with Type 2 Diabetes and Chronic Heart Failure (CANDLE): An Open-Label, Randomized Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3343659 ◽

2019 ◽

Author(s):

Atsushi Tanaka ◽

Itaru Hisauchi ◽

Isao Taguchi ◽

Akira Sezai ◽

Shigeru Toyoda ◽

...

Keyword(s):

Heart Failure ◽

Type 2 Diabetes ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Open Label ◽

RESVERATROL SUPPLEMENTATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE, OPEN LABEL, RANDOMIZED CONTROLLED TRIAL

International Research Journal of Pharmacy ◽

10.7897/2230-8407.04849 ◽

2013 ◽

Vol 4 (8) ◽

pp. 245-249 ◽

Cited By ~ 20

Author(s):

Jayesh Kumar Bhatt ◽

Moola Joghee Nanjan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Open Label ◽

Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2009.03.010 ◽

2009 ◽

Vol 54 (1) ◽

pp. 95-103 ◽

Cited By ~ 44

Author(s):

Katherine A. Barraclough ◽

Kathryn J. Wiggins ◽

Carmel M. Hawley ◽

Carolyn L. van Eps ◽

David W. Mudge ◽

...

Keyword(s):

Hepatitis B ◽

Controlled Trial ◽

Primary Vaccination ◽

Hemodialysis Patients ◽

Hepatitis B Vaccination ◽

Open Label ◽

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

Diabetes Therapy ◽

10.1007/s13300-016-0223-6 ◽

2016 ◽

Vol 8 (1) ◽

pp. 55-73 ◽

Cited By ~ 191

Author(s):

Thomas Haak ◽

Hélène Hanaire ◽

Ramzi Ajjan ◽

Norbert Hermanns ◽

Jean-Pierre Riveline ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Glucose Monitoring ◽

Glucose Sensing ◽

Blood Glucose Monitoring ◽

Open Label ◽

Randomized Controlled ◽

Sensing Technology

730-P: Basal Insulin Regimen vs. Twice-Daily Premix Insulin Regimen after Short-Term Intensive Insulin Therapy (SIT) in Patients with Type 2 Diabetes (T2D): A Multicenter, Open-Label Randomized Controlled Trial

Diabetes ◽

10.2337/db21-730-p ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 730-P

Author(s):

YIMING MU ◽

LIXIN GUO ◽

HAILONG WAN ◽

JUNFEN WANG ◽

BINHUA XU ◽

...

Keyword(s):

Type 2 Diabetes ◽

Intensive Insulin Therapy ◽

Basal Insulin ◽

Controlled Trial ◽

Insulin Regimen ◽

Short Term ◽

Open Label ◽

Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized controlled trial (BEYOND VII)

Diabetes Obesity and Metabolism ◽

10.1111/dom.13967 ◽

2020 ◽

Vol 22 (5) ◽

pp. 838-846

Author(s):

Linong Ji ◽

Hailong Wan ◽

Binhong Wen ◽

Xueying Wang ◽

Junfen Wang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Randomized Controlled ◽

Starting Dose

1102-P: High vs. Standard Starting Dose of Insulin Glargine 100 U/ml in Patients with Overweight/Obesity and Type 2 Diabetes Uncontrolled with Oral Antidiabetic Drugs in China: A Multicenter, Open-Label Randomized Controlled Trial

Diabetes ◽

10.2337/db19-1102-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1102-P

Author(s):

LINONG JI ◽

HAILONG WAN ◽

BINHONG WEN ◽

XUEYING WANG ◽

JUNFEN WANG ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Randomized Controlled ◽

Oral Antidiabetic ◽

Starting Dose

Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12870 ◽

2017 ◽

Vol 19 (5) ◽

pp. 654-663 ◽

Cited By ~ 11

Author(s):

Sang-Mo Hong ◽

Cheol-Young Park ◽

Dong-Min Hwang ◽

Kyung Ah Han ◽

Chang Beom Lee ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Open Label Extension

Intervention of the Flash Glucose Sensing Technology on Glycemic Control and Treatment Satisfaction in Patients with Type 2 Diabetes Treated Intensively by Insulin—A Randomized Controlled Trial

Diabetes ◽

10.2337/db18-908-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 908-P ◽

Cited By ~ 1

Author(s):

MARIANNA YARON ◽

EYTAN ROITMAN ◽

GENYA AHARON-HANANEL ◽

ZOHAR LANDAU ◽

TALI GANZ ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Treatment Satisfaction ◽

Controlled Trial ◽

Glucose Sensing ◽

Randomized Controlled ◽

Sensing Technology

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽